The Mark Cuban Cost Plus Drug Co. will add more than 80 generic drugs to its product list April 14, the company said in an April 11 tweet. Amiodarone, a cardiac dysrhythmia drug; atomoxetine, which treats attention deficit hyperactivity disorder; carbamazepine, an anticonvulsant; and cetirizine, used for seasonal allergies, are among the drugs being added.
The company currently offers 140 low-cost versions of common generic drugs, having added 50 more medications to its list in late March.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
